TABLE 5.
Estimated PROMs and 95% confidence intervals at T1 and T6 for subjects with on‐target rKA and on‐target MA based on GEE models that adjusted for demographic characteristics and clinical measures
| On‐target rKA | On‐target MA | Z Value | P‐value | |
|---|---|---|---|---|
| Estimated change in KOOS12 from baseline | ||||
| T1 | 26.053 (23.658, 28.448) | 18.607 (15.691, 21.523) | 3.90 | < 0.001 |
| T6 | 51.017 (48.567, 53.467) | 46.896 (44.187, 49.605) | 2.28 | 0.023 |
| Estimated change in EQ5D from baseline | ||||
| T1 | 0.457 (0.424, 0.490) | 0.367 (0.334, 0.400) | 4.27 | < 0.001 |
| T6 | 0.606 (0.581, 0.631) | 0.565 (0.538, 0.592) | 2.58 | 0.010 |
| Estimated FJS | ||||
| T1 | 54.126 (48.932, 59.320) | 40.965 (33.750, 48.180) | 3.06 | 0.002 |
| T6 | 66.256 (60.809, 71.703) | 59.581 (52.486, 66.676) | 1.64 | 0.102 |